Cyclophosphamide modulates Wnt3a/β-catenin signaling in MRL/lpr mice with lupus nephritis
American Journal of Clinical and Experimental Immunology · 2025
DOI: 10.62347/fvaq6809 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2025. Verfasst von Shuhong Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Rheumatology, Gansu Provincial Hospital Lanzhou 730000, Gansu, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Rheumatology, Gansu Provincial Hospital Lanzhou 730000, Gansu, China.
- First School of Clinical Medical, Gansu University of Chinese Medicine Lanzhou 730000, Gansu, China.
- Department of Geriatrics, Second People's Hospital of Shaanxi Province Xi'an 710000, Shaanxi, China.
- Department of Rheumatology and Immunology, Affiliated Hospital of Chengde Medical College Chengde 067000, Hebei, China.
- Department of Geriatrics, Second People's Hospital of Lanzhou Lanzhou 730000, Gansu, China.
- Department of Rheumatology and Immunology, Xian Red Cross Hospital Xi'an 710000, Shaanxi, China.
Zitieren
APA
Zhou, S., Liang, L., Zhang, K., Wang, M., Wang, Y., Xu, H., Zhou, J., Chen, Y., Zhang, W., Zhang, H., & Sun, X. (2025). Cyclophosphamide modulates Wnt3a/β-catenin signaling in MRL/lpr mice with lupus nephritis. American Journal of Clinical and Experimental Immunology. https://doi.org/10.62347/fvaq6809
Vancouver
Zhou S, Liang L, Zhang K, Wang M, Wang Y, Xu H, et al. Cyclophosphamide modulates Wnt3a/β-catenin signaling in MRL/lpr mice with lupus nephritis. American Journal of Clinical and Experimental Immunology. 2025. doi:10.62347/fvaq6809
BibTeX
@article{Zhou2025,
author = {Zhou, Shuhong and Liang, Liuna and Zhang, Kai and Wang, Minghao and Wang, Yan and Xu, Hao and Zhou, Jing and Chen, Ying and Zhang, Wangzheqi and Zhang, Haoling and Sun, Xiaowei},
title = {Cyclophosphamide modulates Wnt3a/β-catenin signaling in MRL/lpr mice with lupus nephritis},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2025},
doi = {10.62347/fvaq6809}
}
EUVIMED